Home › Funds › OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM › RNAM

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM position in RNAM

AVIDITY BIOSCIENCES INC

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM reported holding 3,716,597 shares of RNAM (AVIDITY BIOSCIENCES INC) in its Q4 2025 13F filing — a position valued at US$268.1M, representing 7.51% of its reported portfolio and ranking #5 among its reported holdings. OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM first reported this position in Q4 2025.

Latest position (Q4 2025)3.72M sh
Reported value held$268.08M
Portfolio Weight7.51%
First reportedQ4 2025
Last changeNew
Updated2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

How OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's RNAM position evolved

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM first disclosed a stake in RNAM in Q4 2025 at 3,716,597 shares (US$268.1M).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 3.72M $268.08M New

About RNAM and 13F data

RNAM (AVIDITY BIOSCIENCES INC) is a company whose sector is not yet classified in our data. 1 other funds we track also report a position in RNAM. Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RNAM

No other tracked fund reports a position in RNAM.

All RNAM fund holders →

FAQ

How long has OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM held RNAM?

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM has disclosed RNAM holdings in 1 of the last 1 reported quarters, going back to Q4 2025.

What is OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's current position in RNAM?

As of Q4 2025, OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM holds 3.72M shares of RNAM (AVIDITY BIOSCIENCES INC), valued at $268.08M, representing 7.51% of its reported portfolio and ranking #5.

Has OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM been buying or selling RNAM?

In the latest 13F filing (Q4 2025), OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM newly opened its position in RNAM.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.